These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32649312)

  • 21. Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease.
    Zhu Y; Yang B; Wang F; Liu B; Li K; Yin K; Yin WF; Zhou C; Tian S; Ren H; Pang A; Yang X
    J Neuroimmunol; 2021 Sep; 358():577662. PubMed ID: 34311152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease.
    Bäckström D; Eriksson Domellöf M; Granåsen G; Linder J; Mayans S; Elgh E; Zetterberg H; Blennow K; Forsgren L
    Acta Neurol Scand; 2018 Jan; 137(1):91-98. PubMed ID: 28869277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
    Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and neuropsychological features and changes to regional cerebral blood flow in ‍patients with Parkinson's disease dementia].
    Kuroha Y; Takahashi T; Arai Y; Yoshino M; Kasuga K; Hasegawa A; Matsubara N; Koike R; Ikeuchi T
    Rinsho Shinkeigaku; 2024 Sep; 64(9):623-631. PubMed ID: 39198159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of Mild Cognitive Impairment and Dementia in Parkinson's Disease: The Parkinson's Disease Cognitive Impairment Study.
    Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; Pilati L; Restivo V; Zappia M; Monastero R
    Front Aging Neurosci; 2019; 11():21. PubMed ID: 30800065
    [No Abstract]   [Full Text] [Related]  

  • 27. Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.
    Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A
    Mov Disord; 2008 May; 23(7):998-1005. PubMed ID: 18381647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Multiple Object Test as a Performance Based Tool to Assess Cognitive Driven Activity of Daily Living Function in Parkinson's Disease.
    Glonnegger H; Beyle A; Cerff B; Gräber S; Csoti I; Berg D; Liepelt-Scarfone I
    J Alzheimers Dis; 2016 Jul; 53(4):1475-84. PubMed ID: 27392856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Home-Based Physical Behavior in Late Stage Parkinson Disease Dementia: Differences between Cognitive Subtypes.
    Cerff B; Maetzler W; Sulzer P; Kampmeyer M; Prinzen J; Hobert MA; Blum D; van Lummel R; Del Din S; Gräber S; Berg D; Liepelt-Scarfone I
    Neurodegener Dis; 2017; 17(4-5):135-144. PubMed ID: 28441649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.
    Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Pascual-Sedano B; Campolongo A; Kulisevsky J
    Mov Disord; 2013 Sep; 28(10):1376-83. PubMed ID: 23873810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates.
    Orfei MD; Assogna F; Pellicano C; Pontieri FE; Caltagirone C; Pierantozzi M; Stefani A; Spalletta G
    Parkinsonism Relat Disord; 2018 Sep; 54():62-67. PubMed ID: 29709507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular risk factors, white matter lesions and cognitive impairment in Parkinson's disease: the PACOS longitudinal study.
    Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; La Bianca G; Restivo V; Zappia M; Monastero R
    J Neurol; 2021 Feb; 268(2):549-558. PubMed ID: 32865628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between serum 25(OH)D and cognitive impairment in Parkinson's disease.
    Wu H; Khuram Raza H; Li Z; Li Z; Zu J; Xu C; Yang D; Cui G
    J Clin Neurosci; 2022 Jun; 100():192-195. PubMed ID: 35489254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum level of YWHAG as a diagnostic marker of cognitive impairment in Parkinson's disease patients.
    Peng Y; Zhu L; Bai Q; Wang L; Li Q
    Acta Neurol Belg; 2024 Jun; 124(3):879-885. PubMed ID: 38286872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological impairment in Parkinson's disease with and without depression.
    Tröster AI; Stalp LD; Paolo AM; Fields JA; Koller WC
    Arch Neurol; 1995 Dec; 52(12):1164-9. PubMed ID: 7492290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinson's disease dementia: Diagnostic criteria and risk factor review.
    Vasconcellos LF; Pereira JS
    J Clin Exp Neuropsychol; 2015; 37(9):988-93. PubMed ID: 26332178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between Thyroid Hormones and Cognitive Impairment in Patients with Parkinson's Disease.
    Peng Y; Zhu L; Bai Q; Wang L; Li Q
    eNeuro; 2024 Oct; 11(10):. PubMed ID: 39288996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive profile as a predictor of the long-term outcome after deep brain stimulation in Parkinson's disease.
    Park KW; Jo S; Kim MS; Choi N; Jeon SR; Park HK; Kwon KY; Lee CS; Chung SJ
    J Neurol Sci; 2020 Oct; 417():117063. PubMed ID: 32777578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS).
    Monastero R; Cicero CE; Baschi R; Davì M; Luca A; Restivo V; Zangara C; Fierro B; Zappia M; Nicoletti A
    J Neurol; 2018 May; 265(5):1050-1058. PubMed ID: 29478221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.